We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $127B
1-Year Est. Return 44.11%
This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$143B
AUM Growth
+$8.87B
Cap. Flow
-$4.28B
Cap. Flow %
-2.99%
Top 10 Hldgs %
29.69%
Holding
331
New
12
Increased
93
Reduced
185
Closed
4

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$585M
2
TXN icon
Texas Instruments
TXN
+$465M
3
ADBE icon
Adobe
ADBE
+$422M
4
NVDA icon
NVIDIA
NVDA
+$404M
5
QCOM icon
Qualcomm
QCOM
+$333M

Sector Composition

Rank Sector Weight
1 Technology 31.13%
2 Healthcare 25.39%
3 Industrials 13.4%
4 Consumer Discretionary 11.33%
5 Financials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENOV icon
226
Enovis
ENOV
$1.6B
$26.9M 0.02%
357,083
-24,227
-6% -$1.78M
WVE icon
227
Wave Life Sciences
WVE
$1.15B
$26.2M 0.02%
4,665,950
+741,475
+19% +$7.12M
MATX icon
228
Matsons
MATX
$6.18B
$26.2M 0.02%
392,292
-142,100
-27% -$9.73M
NUVA
229
DELISTED
NuVasive, Inc.
NUVA
$26.2M 0.02%
399,000
-95,500
-19% -$5.73M
CALA
230
DELISTED
Calithera Biosciences, Inc
CALA
$25M 0.02%
516,685
+4,010
+0.8% +$233K
NVT icon
231
nVent Electric
NVT
$23.7B
$24.8M 0.02%
887,900
LAB icon
232
Standard BioTools
LAB
$309M
$24.5M 0.02%
5,420,743
-13,100
-0.2% -$72K
ULTA icon
233
Ulta Beauty
ULTA
$20.7B
$23.3M 0.02%
75,300
BBIO icon
234
BridgeBio Pharma
BBIO
$16.6B
$21.9M 0.02%
+355,237
New +$23.2M
GH icon
235
Guardant Health
GH
$19.2B
$21.5M 0.02%
140,952
+12,900
+10% +$1.95M
FOLD
236
DELISTED
Amicus Therapeutics
FOLD
$21M 0.01%
2,130,000
SCOR icon
237
Comscore
SCOR
$106M
$20.1M 0.01%
274,398
DOOR
238
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$20M 0.01%
173,500
-14,200
-8% -$1.54M
GSK icon
239
GSK
GSK
$104B
$20M 0.01%
447,440
GAN
240
DELISTED
GAN Ltd
GAN
$19.7M 0.01%
1,083,200
+162,200
+18% +$4.11M
ARE icon
241
Alexandria Real Estate Equities
ARE
$8.97B
$19.6M 0.01%
119,500
SPHR icon
242
Sphere Entertainment
SPHR
$4.95B
$17.7M 0.01%
215,873
+11,175
+5% +$1.11M
PRSP
243
DELISTED
Perspecta Inc. Common Stock
PRSP
$16.9M 0.01%
580,564
-58,774
-9% -$1.66M
MASS icon
244
908 Devices
MASS
$288M
$15.9M 0.01%
328,600
+3,600
+1% +$206K
GTM
245
ZoomInfo Technologies
GTM
$928M
$15.6M 0.01%
319,089
-57,821
-15% -$2.9M
RPD icon
246
Rapid7
RPD
$660M
$15.4M 0.01%
206,700
+8,850
+4% +$735K
MTLS
247
Materialise
MTLS
$374M
$14.5M 0.01%
403,724
-157,576
-28% -$8.77M
CVGW
248
DELISTED
Calavo Growers
CVGW
$14.2M 0.01%
183,400
SAIC icon
249
Saic
SAIC
$5.02B
$14M 0.01%
167,800
PEN icon
250
Penumbra
PEN
$12.6B
$14M 0.01%
51,590
-530
-1% -$137K

Similar funds

Primecap Management's Q1 2021 Portfolio in Review

As of Q1 2021, Primecap Management held 331 positions worth $143B, up 6.6% from $135B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 4.8%. Primecap Management opened 12 new positions and exited 4, leaving the 331-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Primecap Management's largest Q1 2021 buy was WEX: 566,350 shares worth $118M.
  • Primecap Management added most to Alibaba in Q1 2021, an estimated $640M increase.
  • Primecap Management's biggest Q1 2021 reduction was Tesla, cutting an estimated $585M.
  • Primecap Management fully exited Chevron in Q1 2021, selling an estimated $20.2M.
  • Primecap Management's ten largest holdings make up 30% of its $143B portfolio in Q1 2021.
  • Primecap Management opened 12 new positions and closed 4 in Q1 2021.
  • Primecap Management's portfolio value rose 6.6% quarter-over-quarter to $143B.

Based on Primecap Management's 13F filing for Q1 2021, filed 14 May 2021.